These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Therapeutic use of dapsone in dermatitis herpetiformis (Duhring) and in certain inflammatory skin diseases]. Révész K; Schneider I Orv Hetil; 1995 Jan; 136(2):59-62. PubMed ID: 7862431 [TBL] [Abstract][Full Text] [Related]
29. Possible dapsone-induced peripheral neuropathy in dermatitis herpetiformis. du Vivier A; Fowler T Proc R Soc Med; 1974 Jun; 67(6 Pt 1):439-40. PubMed ID: 4369028 [No Abstract] [Full Text] [Related]
30. "Sulfoxone (Diasone) sodium for dermatitis herpetiformis" by Cornbleet, December 1951. Commentary: Sulfoxone (Diasone) in the treatment of dermatitis herpetiformis. Katz SI Arch Dermatol; 1982 Oct; 118(10):805-12. PubMed ID: 6753759 [No Abstract] [Full Text] [Related]
31. Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone. Molinelli E; Paolinelli M; Campanati A; Brisigotti V; Offidani A Expert Opin Drug Metab Toxicol; 2019 May; 15(5):367-379. PubMed ID: 30943794 [TBL] [Abstract][Full Text] [Related]
32. Chemotherapy of leprosy. Shepard CC Annu Rev Pharmacol; 1969; 9():37-50. PubMed ID: 4892433 [No Abstract] [Full Text] [Related]
33. [What do we know today about diaminodiphenylsulfone?]. Golusin Z; Poljacki M; Preveden R; Stojanović S; Rajić N Med Pregl; 2000; 53(7-8):369-72. PubMed ID: 11214480 [TBL] [Abstract][Full Text] [Related]
34. Methemoglobinemia from dapsone therapy for a suspected brown spider bite. Iserson KV J Emerg Med; 1985; 3(4):285-8. PubMed ID: 4093581 [TBL] [Abstract][Full Text] [Related]
35. Patient compliance with dapsone administration in leprosy. Huikeshoven H Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):228-58. PubMed ID: 7024150 [No Abstract] [Full Text] [Related]
36. Case records of the Massachusetts General Hospital: Case 7-2011: a 52-year-old man with upper respiratory symptoms and low oxygen saturation levels. Pallais JC; Mackool BT; Pitman MB N Engl J Med; 2011 Mar; 364(10):957-66. PubMed ID: 21388314 [No Abstract] [Full Text] [Related]
37. Fatal hemolysis from mafenide treatment of burns in a patient with glucose-6-phosphate dehydrogenase deficiency. Case report. Marsicano AR; Hutton JJ; Bryant WM Plast Reconstr Surg; 1973 Aug; 52(2):197-9. PubMed ID: 4722683 [No Abstract] [Full Text] [Related]
38. [Use of synthetic ACTH in the therapy of dermatologic diseases]. Schuppli R Dermatologica; 1969; 139(4):243-53. PubMed ID: 4392894 [No Abstract] [Full Text] [Related]
39. Dapsone-induced methemoglobinemia: an anesthetic risk. Szeremeta W; Dohar JE Int J Pediatr Otorhinolaryngol; 1995 Aug; 33(1):75-80. PubMed ID: 7558644 [TBL] [Abstract][Full Text] [Related]